DES Breast Cancer Trial Is Over – More Details

9 Jan
Dr. Hans-Olov Adami, the Harvard Department of Publish Health, testified that the evidence is so compelling that even the Harvard Women’s Health Watch and the Institute of Medicine of the National Academies stated that mothers and daughters “who were exposed to pharmacological levels of DES in utero experienced important and devastating effects many years later, including an elevated risk of breast cancer”
Dr. Adami testified that epidemiological evidence was not only applicable to the DES daughters, but to ANY DES daughter who developed breast cancer above the age of 40 or 50 so long as they did not have any other unusually high breast cancer risk factors.
He testified that the experiment on women in the case of DES was truly a human tragedy, as he published in the European Journal of Epidemiology.
Eli Lilly did not even complete their cross examination of Dr. Adami, when they, during a break, approached the Plaintiffs and the Judge to settle the case with an undisclosed sum.  

One Response to “DES Breast Cancer Trial Is Over – More Details”

  1. anniedianni at 10:04 pm #

    Eli Lilly et al are total scumbags. They have drug (no pun intended) this case out far too long, in view of the FACT that many of us are sick from the effect of chemo and breast cancer. Did they think this was a game?

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: